Evidence map›Paper›PMID 33444388›Full record

ArticlePLoS pathogens2021

Orthopoxvirus K3 orthologs show virus- and host-specific inhibition of the antiviral protein kinase PKR.

Chorong Park, Chen Peng, M Julhasur Rahman, Sherry L Haller, Loubna Tazi, Greg Brennan, Stefan Rothenburg

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
5.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 48 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. The strategies and advances of mRNA translation booster.Asian journal of pharmaceutical sciences · 2025
    Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Review
  14. Protein Kinase R (PKR) as a Novel dsRNA Sensor in Antiviral Innate Immunity.Methods in molecular biology (Clifton, N.J.) · 2025
    Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Chorong ParkSchool of Medicine, University of California Davis, Department of Medial Microbiology and Immunology, Davis, California, United States of America.ORCID 0000-0001-5751-5767
Chen PengNational Institute of Allergy and Infectious Diseases, National Institutes of Health, Laboratory of Viral Diseases, Bethesda, Maryland, United States of America.
M Julhasur RahmanSchool of Medicine, University of California Davis, Department of Medial Microbiology and Immunology, Davis, California, United States of America.ORCID 0000-0003-2113-369X
Sherry L HallerUniversity of Texas Medical Branch at Galveston, Department of Microbiology and Immunology, Galveston, Texas, United States of America.
Loubna TaziSchool of Medicine, University of California Davis, Department of Medial Microbiology and Immunology, Davis, California, United States of America.ORCID 0000-0003-1300-0010
Greg BrennanSchool of Medicine, University of California Davis, Department of Medial Microbiology and Immunology, Davis, California, United States of America.ORCID 0000-0002-4339-9045
Stefan RothenburgSchool of Medicine, University of California Davis, Department of Medial Microbiology and Immunology, Davis, California, United States of America.ORCID 0000-0002-2525-8230
University of California, Davis · USNational Institutes of Health · USThe University of Texas Medical Branch at Galveston · US

Funding

Importance of Species-Specific Interactions of PKR with Poxvirus Inhibitors for Virus Replication and Host RangeR01AI114851 · NIAID · UNIVERSITY OF CALIFORNIA AT DAVIS · PI ROTHENBURG, STEFAN · 2015 to 2019
$1.8M
NIAID NIH HHS R01 AI114851
6 · The paper itself

Abstract

The antiviral protein kinase R (PKR) is an important host restriction factor, which poxviruses must overcome to productively infect host cells. To inhibit PKR, many poxviruses encode a pseudosubstrate mimic of the alpha subunit of eukaryotic translation initiation factor 2 (eIF2), designated K3 in vaccinia virus. Although the interaction between PKR and eIF2α is highly conserved, some K3 orthologs from host-restricted poxviruses were previously shown to inhibit PKR in a species-specific manner. To better define this host range function, we compared the sensitivity of PKR from 17 mammals to inhibition by K3 orthologs from closely related orthopoxviruses, a genus with a generally broader host range. The K3 orthologs showed species-specific inhibition of PKR and exhibited three distinct inhibition profiles. In some cases, PKR from closely related species showed dramatic differences in their sensitivity to K3 orthologs. Vaccinia virus expressing the camelpox virus K3 ortholog replicated more than three orders of magnitude better in human and sheep cells than a virus expressing vaccinia virus K3, but both viruses replicated comparably well in cow cells. Strikingly, in site-directed mutagenesis experiments between the variola virus and camelpox virus K3 orthologs, we found that different amino acid combinations were necessary to mediate improved or diminished inhibition of PKR derived from different host species. Because there is likely a limited number of possible variations in PKR that affect K3-interactions but still maintain PKR/eIF2α interactions, it is possible that by chance PKR from some potential new hosts may be susceptible to K3-mediated inhibition from a virus it has never previously encountered. We conclude that neither the sensitivity of host proteins to virus inhibition nor the effectiveness of viral immune antagonists can be inferred from their phylogenetic relatedness but must be experimentally determined.

Indexed as

Host SpecificityVirus ReplicationAmino Acid SequenceAnimalsAntiviral AgentseIF-2 KinaseHeLa CellsHumansOrthopoxvirusPhosphorylationPhylogenyPoxviridae InfectionsSequence HomologyAntiviral AgentseIF-2 Kinase

Identifiers

PMID33444388
PMCPMC7840043
OpenAlexW3120542492

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.